Literature DB >> 11230894

Type I collagen turnover and cross-linking are increased in irradiated skin of breast cancer patients.

M Sassi1, A Jukkola, R Riekki, M Höyhtyä, L Risteli, A Oikarinen, J Risteli.   

Abstract

BACKGROUND AND
PURPOSE: The effects of radiation therapy on the turnover and structure of type I collagen were studied in irradiated and contralateral skin of 18 breast cancer patients without clinically evident fibrosis.
MATERIALS AND METHODS: The rates of on-going type I collagen synthesis and degradation were assessed by the aminoterminal propeptide of type I procollagen (PINP) and by two different assays (ICTP and SP4) for the carboxyterminal telopeptide of type I collagen in the soluble tissue extracts, respectively. Also, TIMP-1, TIMP-2 and the MMP-2/TIMP-2 complex were measured in the tissue extracts. Insoluble skin matrices, containing the cross-linked type I collagen fibres, were heat-denatured and digested with trypsin. Then, the variants of the carboxyterminal telopeptide of type I collagen were separated by high performance liquid chromatography (HPLC). The major histidinohydroxylysinonorleucine (HHL)-cross-linked variant was quantified by the SP4 assay, and the minor pyridinoline analogue (PA)-cross-linked telopeptide was quantified by the ICTP assay.
RESULTS: Both the synthesis and degradation of type I collagen were increased (r=0.906; P<0.001) on the irradiated side, whereas the concentration of the MMP-2/TIMP-2 complex was decreased. In the insoluble tissue digests, the HHL-cross-linked telopeptides of type I collagen, also, when expressed/tissue hydroxyproline, were increased in the irradiated skin. TIMP-1, TIMP-2 or PA-cross-linked telopeptides of type I collagen showed no differences between the two sides.
CONCLUSIONS: Radiotherapy induces a long-term increase in the turnover of type I collagen and leads to the accumulation of cross-linked type I collagen in skin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230894     DOI: 10.1016/s0167-8140(00)00253-x

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

Review 1.  Radiotherapy and wound healing.

Authors:  Emma-Louise Dormand; Paul E Banwell; Timothy E E Goodacre
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

Review 2.  Treatment of Radiation Injury.

Authors:  Sadanori Akita
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-01-01       Impact factor: 4.730

3.  Topical Deferoxamine Alleviates Skin Injury and Normalizes Atomic Force Microscopy Patterns Following Radiation in a Murine Breast Reconstruction Model.

Authors:  Alicia E Snider; Jeremy V Lynn; Kevin M Urlaub; Alexis Donneys; Yekaterina Polyatskaya; Noah S Nelson; Russell E Ettinger; Geoffrey C Gurtner; Mark M Banaszak Holl; Steven R Buchman
Journal:  Ann Plast Surg       Date:  2018-11       Impact factor: 1.539

4.  Radiotherapy of early breast cancer in scleroderma patients: our experience with four cases and a short review of the literature.

Authors:  George Kyrgias; Kiki Theodorou; Anna Zygogianni; Konstantinos Tsanadis; Stefanos Zervoudis; John Tzitzikas; Michael Koukourakis
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-01-24

5.  Removal of dentin non-collagenous structures results in the unraveling of microfibril bundles in collagen type I.

Authors:  Luiz E Bertassoni; Michael V Swain
Journal:  Connect Tissue Res       Date:  2016-09-22       Impact factor: 3.417

6.  Focal therapeutic irradiation induces an early transient increase in bone glycation.

Authors:  Megan E Oest; Timothy A Damron
Journal:  Radiat Res       Date:  2014-04-04       Impact factor: 2.841

7.  An expression analysis of markers of radiation-induced skin fibrosis and angiogenesis in wound healing disorders of the head and neck.

Authors:  Steffen Koerdt; Nils H Rohleder; Niklas Rommel; Christopher Nobis; Mechthild Stoeckelhuber; Steffi Pigorsch; Marciana-Nona Duma; Klaus-Dietrich Wolff; Marco R Kesting
Journal:  Radiat Oncol       Date:  2015-09-22       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.